Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.

ABSTRACT:

SUBMITTER: Dixon B 

PROVIDER: S-EPMC7826120 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature